XML 69 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes (Tables)
12 Months Ended
Sep. 28, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income Before Provision For (Benefit From) Income Taxes
The Company’s income (loss) before provision for income taxes for fiscal 2024, 2023 and 2022 were as follows:
September 28,
2024
September 30,
2023
October 1,
2022
(In thousands)
Domestic$(56,661)$(9,904)$54,609 
Foreign29,510 14,298 14,121 
Income (loss) before provision for income taxes
$(27,151)$4,394 $68,730 
Schedule of Provision For (Benefit From) Income Taxes
Components of the provision for income taxes consisted of the following:
September 28,
2024
September 30,
2023
October 1,
2022
(In thousands)
Current:
U.S. Federal$8,094 $7,507 $— 
U.S. State4,023 4,947 483 
Foreign17,798 2,810 3,401 
Total current29,915 15,264 3,884 
Deferred:
U.S. Federal— — (1,459)
U.S. State— — (21)
Foreign(18,920)(596)(1,057)
Total deferred(18,920)(596)(2,537)
Provision for income taxes$10,995 $14,668 $1,347 
Schedule of Deferred Tax Assets and Liabilities
Components of the Company’s deferred income tax assets and liabilities are as follows:
September 28,
2024
September 30,
2023
(In thousands)
Deferred tax assets
Capitalized research & development$107,474 $63,395 
Research & development tax credit carryforwards58,156 75,593 
Accrued expenses and reserves17,070 17,837 
Deferred revenue15,374 15,855 
Operating lease liability14,259 13,097 
Other capitalized costs12,030 5,364 
Stock-based compensation8,195 7,727 
Foreign net operating loss carryforwards5,783 7,606 
Depreciation2,991 2,700 
U.S. net operating loss carryforwards2,296 1,852 
Other592 494 
Total deferred tax assets244,220 211,520 
Valuation allowance(216,365)(185,840)
Deferred tax assets, net of valuation allowance27,855 25,680 
Deferred tax liabilities
Right-of-use asset(10,955)(11,392)
Intangibles(3,392)(22,475)
Capitalized inventory
(3,254)— 
Total deferred tax liabilities(17,601)(33,867)
Net deferred tax assets (liabilities)$10,254 $(8,187)
Reported as
Deferred tax assets$10,314 $1,659 
Deferred tax liabilities(60)(9,846)
Net deferred tax assets (liabilities)$10,254 $(8,187)
Summary of Changes in Valuation Allowance
The following table summarizes changes in the valuation allowance for fiscal 2024, 2023 and 2022:
September 28,
2024
September 30,
2023
October 1,
2022
(In thousands)
Beginning balance$185,840 $162,267 $155,978 
Increase during the period32,573 23,628 13,841 
Decrease during the period(2,048)(55)(7,552)
Ending balance$216,365 $185,840 $162,267 
Schedule of Effective Income Tax Rate Reconciliation
Reconciliation of U.S. statutory federal income taxes to the Company’s provision for income taxes is as follows:
September 28,
2024
September 30,
2023
October 1,
2022
(In thousands)
U.S. federal income taxes at statutory rate$(5,702)$923 $14,433 
U.S. state and local income taxes, net of federal benefit and state credits(2,496)(841)(2,594)
Foreign income tax rate differential1,544 734 970 
Stock-based compensation2,726 104 (15,532)
Federal research and development tax credits(8,240)(7,591)(8,983)
Unrecognized federal tax benefits1,082 184 (2,482)
Change in tax rate(188)— 5,013 
Global intangible low taxed income, net of foreign tax credits944 1,234 290 
Foreign -derived intangible income (FDII) deduction(1,519)(6,863)— 
Subpart F income733 1,374 — 
162(m) executive compensation limitation1,496 2,513 2,574 
Deferred adjustments504 — — 
Intercompany IP sale(10,412)— — 
Other(121)(695)1,079 
Change in valuation allowance30,644 23,592 6,579 
Provision for income taxes$10,995 $14,668 $1,347 
Schedule of Changes in Unrecognized Tax Benefits
Change in gross unrecognized tax benefits, excluding interest and penalties, as a result of uncertain tax positions are as follows:
September 28,
2024
September 30,
2023
October 1,
2022
(In thousands)
Beginning balance$17,619 $17,021 $21,252 
Increase (decrease) - tax positions in prior periods
147 (566)(6,039)
Increase - tax positions in current periods1,144 1,164 1,808 
Ending balance$18,910 $17,619 $17,021